The pharmaceutical company Reig Jofre reduced its profit by 17% in the first quarter of 2026 compared to the same period last year, to 3.1 million euros, as reported by the company to the National Securities Market Commission (CNMV).
The pharmaceutical company Reig Jofre reduced its profit by 17% in the first quarter of 2026 compared to the same period last year, to 3.1 million euros, as reported by the company to the National Securities Market Commission (CNMV).